Women and children must be prioritised for treatment for HIV/AIDS, appropriate treatment for children must be developed and healthcare infrastructure must be developed as a matter of urgency. This is according to a report from the Save the Children Fund that aims to examine the implications of expanded access to HIV/AIDS treatment, as exemplified by the 3 by 5 initiative, for prevention of HIV in children and young people, and expanding support and care for orphans and other children made vulnerable by HIV/AIDS.
Equity and HIV/AIDS
Equity and access to HIV/AIDS treatment
All people with HIV/AIDS should have equal opportunity to access effective and appropriate treatment. However, in the context of existing social and health inequities, widespread poverty, high rates of new HIV infections, famine and budgetary constraints, increasing access to HIV care and treatment must be organised in a manner that balances HIV prevention and treatment efforts; HIV interventions and the broader strengthening of the health system as a whole; and HIV care and treatment with other public health and social needs.
Extending antiretroviral therapy to resource-poor settings: implications for drug resistance
The emergence of drug resistance in human immunodeficiency virus type 1 (HIV-1) may limit the clinical benefits of antiretroviral therapy. There is no objective evidence that the risk of drug resistance is greater in resource-limited settings than in the developed world. Treatment programmes will be most successful at preventing the spread of drug resistance if they provide healthcare infrastructures to maximize the effectiveness of antiretroviral therapy through the use of potent and convenient combination regimens that achieve durable suppression of HIV-1 replication.
Facing the future together
Report of the Secretary-General\'s Task Force on Women, Girls and HIV/AIDS in Southern Africa
This UNAIDS report, from the Secretary-General’s Task Force on Women, Girls and HIV/AIDS in Southern Africa, presents empirical data on the scale and character of the pandemic in nine countries in Southern Africa with the highest HIV prevalence rates. As the majority of young people aged 15-24 living with AIDS in these countries are women, the report calls for an end to gender inequality, which is key to the spread of HIV among women.
Manufacture of anti-AIDS drugs set to begin in Zambia
A Zambian government initiative to begin the local manufacture of cheap generic antiretroviral (ARV) drugs has been welcomed by AIDS activists. "We have been lobbying for affordable drugs for 10 years. This is a dream come true," said coordinator of the Network of Zambian People Living with HIV/AIDS (NZP+), Clement Mfuzi. "As NZP+, our hope has not only been accessibility, but also affordable drugs. We also hope the supply will be sustainable, because once you take these drugs, it is for life."
Budgeting for HIV/AIDS in South Africa
This report from the South African Budget Information Service (IDASA) analyses budget allocations and funding flows from the national fiscus for HIV/AIDS interventions. It investigates the best way to deliver funds to the provinces of South Africa to tackle HIV/AIDS. Analysis of official budget documents and interviews with national and provincial social service and treasury officials reveals that provinces are generally improving their spending on the HIV/AIDS conditional grants and beginning to allocate significant funds from provincial budgets to tackling HIV/AIDS.
Cash released for free anti-AIDS treatment in Tanzania
People living with HIV/AIDS in Tanzania will soon have access to free antiretroviral drugs under the government's four-year treatment programme. More than US $1.8 million was recently released by the Treasury Department for the Ministry of Health to purchase anti-AIDS drugs, a local newspaper, The Guardian, reported.
Food security, livelihoods and HIV/AIDS
This paper is intended both for managers and technical staff working either in food security and livelihoods or in HIV/AIDS and reproductive health who require an introduction to the linkages between the two areas, and as a guide to the many issues that need to be considered when carrying out assessments (or reviewing others’ assessments) and when planning interventions. The focus is specifically on economic impacts of AIDS, and does not address important emotional, psychological and social impacts.
HIV/AIDS threatening subsistence agriculture in Mozambique
HIV/AIDS is threatening subsistence agriculture in Mozambique, with "ominous implications" for the country's food supply, the Food and Agriculture Organisation (FAO) has warned. By 2020 the country will have lost over 20 percent of its agricultural labour force to HIV/AIDS, according to FAO. Mozambique and Namibia feature among the nine hardest-hit African countries, all in southern and eastern Africa, where FAO predicts a loss of agricultural labour to the disease.
South Africa AIDS drug giant tackled over high prices
The US-based NGO, AIDS Healthcare Foundation (AHF), has lodged a complaint with South Africa's Competition Tribunal against leading anti-AIDS drug producer, GlaxoSmithKline (GSK), saying Glaxo's high drug prices are preventing the treatment of more HIV-positive South Africans. A local newspaper, Business Day, quoted AHF president Michael Weinstein as saying: "We have had to turn people away from our clinic because we simply don't have the funds to treat all the people who need treatment. If the price of GSK's AIDS drugs had been lower, we might have been able to save their lives."